Pfizer says Covid-19 pill near 90 percent protective against hospitalisation, death

Nobody in the trial who received the Pfizer treatment died, compared with 12 deaths among placebo recipients.

Pfizer on Tuesday said its antiviral Covid-19 pill showed near 90 percent efficacy in preventing hospitalizations and deaths in high-risk patients, and recent lab data suggests the drug retains its effectiveness against the fast spreading Omicron variant of the coronavirus.